Verastem Ownership | Who Owns Verastem?
Verastem Ownership Summary
Verastem is owned by 12.54% institutional investors, 0.67% insiders, and 86.79% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 9.49% of VSTM shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.84% of its assets in Verastem shares.
VSTM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Verastem | 12.54% | 0.67% | 86.79% |
| Sector | Healthcare Stocks | 35.64% | 12.08% | 52.28% |
| Industry | Biotech Stocks | 35.43% | 12.01% | 52.56% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rtw investments, lp | 6.58M | 9.49% | $34.85M |
| Blackrock funding, inc. /de | 6.19M | 8.94% | $32.83M |
| Deep track capital, lp | 5.74M | 8.28% | $30.43M |
| Armistice capital | 4.59M | 6.63% | $24.34M |
| Vanguard group | 4.15M | 5.68% | $32.06M |
| Nantahala capital management | 3.58M | 5.17% | $19.00M |
| State street | 3.52M | 5.07% | $18.64M |
| Stonepine capital management | 3.30M | 4.76% | $17.50M |
| Foresite capital management vi | 3.15M | 4.54% | $16.68M |
| Millennium management | 2.41M | 3.48% | $12.78M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Stonepine capital management | 3.30M | 7.01% | $17.50M |
| Rosalind advisors | 2.14M | 4.55% | $11.33M |
| Foresite capital management vi | 3.15M | 3.62% | $16.68M |
| Acorn capital advisors | 1.47M | 2.21% | $7.79M |
| Exome asset management | 636.70K | 1.75% | $3.37M |
| Aigh capital management | 2.00M | 1.45% | $10.60M |
| Nantahala capital management | 3.58M | 0.70% | $19.00M |
| Deep track capital, lp | 5.74M | 0.50% | $30.43M |
| Birchview capital, lp | 150.00K | 0.45% | $795.00K |
| Armistice capital | 4.59M | 0.43% | $24.34M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Nantahala capital management | 3.58M | 0.70% | 3.12M |
| Alyeska investment group | 2.05M | 0.03% | 2.05M |
| Aigh capital management | 2.00M | 1.45% | 2.00M |
| Millennium management | 2.41M | 0.01% | 1.86M |
| Blackrock funding, inc. /de | 6.19M | 0.00% | 1.44M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Polar capital | - | - | -3.93M |
| Bvf inc/il | - | - | -3.40M |
| Balyasny asset management | 409.78K | 0.00% | -2.79M |
| Farallon capital management | - | - | -2.00M |
| Octagon capital advisors lp | - | - | -1.72M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Alyeska investment group | 2.05M | 0.03% | 2.05M | $10.87M |
| Aigh capital management | 2.00M | 1.45% | 2.00M | $10.60M |
| Longaeva partners | 807.75K | 0.16% | 807.75K | $4.28M |
| Baker bros. advisors lp | 584.76K | 0.02% | 584.76K | $3.10M |
| Vanguard fiduciary trust | 494.69K | 0.00% | 494.69K | $2.62M |
Sold Out
| Holder | Change |
|---|---|
| Evermay wealth management | -6.00 |
| Grove bank & trust | -8.00 |
| Federation des caisses desjardins du quebec | -13.00 |
| Wealthspire advisors | -20.00 |
| Financial consulate | -30.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 56 | -62.67% | 10,462,403 | -86.32% | 12 | 0.11% | 35 | -63.54% | 13 | -58.06% |
| Dec 31, 2025 | 81 | -34.15% | 38,606,066 | -35.25% | 52 | 0.65% | 52 | -24.64% | 16 | -56.76% |
| Sep 30, 2025 | 118 | 2.61% | 56,748,047 | 7.93% | 85 | 1.36% | 66 | -12.00% | 36 | 63.64% |
| Jun 30, 2025 | 115 | 12.75% | 52,579,832 | 21.50% | 79 | 1.25% | 74 | 34.55% | 22 | -18.52% |
| Mar 31, 2025 | 102 | 9.68% | 43,276,247 | 24.92% | 79 | 1.08% | 55 | -17.91% | 27 | 200.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 3.38M | 3.84% | -75.18K |
| Vanguard Total Stock Mkt Idx Inv | 2.81M | 3.20% | 511.76K |
| RTW Biotech Opportunities Ord | 1.92M | 2.55% | 1.92M |
| Vanguard US Total Market Shares ETF | 1.22M | 2.37% | - |
| iShares Russell 2000 ETF | 2.08M | 2.37% | 12.34K |
| SPDR® S&P Biotech ETF | 1.28M | 2.08% | 2.85K |
| Kennedy Micro Cap | 547.19K | 1.36% | 359.19K |
| Vanguard Institutional Extnd Mkt Idx Tr | 960.21K | 1.09% | 132.78K |
| BlackRock Advantage Small Cap Core Instl | 939.96K | 1.07% | 238.62K |
| Polar Capital Biotech S Inc | 787.74K | 0.90% | -2.71M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 22, 2026 | Paterson Dan | President and CEO | Sell | $87.24K |
| Jun 22, 2026 | Calkins Daniel | Chief Financial Officer | Sell | $16.85K |
| Jun 22, 2026 | Calkins Daniel | Chief Financial Officer | Sell | $235.41 |
| May 04, 2026 | Paterson Dan | President and CEO | Sell | $4.69K |
| Feb 04, 2026 | Paterson Dan | President and CEO | Sell | $6.49K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 4 |
| 2026 Q1 | - | 3 |
| 2025 Q4 | - | 23 |
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | 9 |
VSTM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools